Instil Bio (TIL) Construction in Progress (2020 - 2022)
Instil Bio (TIL) posted quarterly Construction in Progress of $104.0 million for Q4 2022, up 55.22% year-over-year from $67.0 million in Q4 2021, and up 55.22% quarter-over-quarter from $67.0 million in Q4 2021.
Instil Bio (TIL) Construction in Progress (2020 - 2022) Analysis & Trends
Instil Bio's Construction in Progress history runs 3 years deep, the most recent figure standing at $104.0 million for Q4 2022.
- In Q4 2022, Construction in Progress rose 55.22% year-over-year to $104.0 million; the TTM figure through Dec 2022 stood at $104.0 million (up 55.22% YoY), while the FY2022 annual figure was $104.0 million, up 55.22% from the prior year.
- Construction in Progress for Q4 2022 stood at $104.0 million, up from $67.0 million in the prior quarter.
- The five-year high for Construction in Progress was $104.0 million in Q4 2022, with the low at $6.3 million in Q4 2020.
- The 3-year median for Construction in Progress is $44.2 million (2021), against an average of $48.8 million.
- The sharpest annual moves came in 2021 and 2022: Construction in Progress soared 963.49% in 2021, then soared 55.22% in 2022.
- Instil Bio's Construction in Progress stood at $6.3 million in 2020, then jumped by 963.49% to $67.0 million in 2021, then jumped by 55.22% to $104.0 million in 2022.
- Business Quant data shows TIL's Construction in Progress at $104.0 million in Q4 2022, $67.0 million in Q4 2021, and $44.2 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 152.67 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Instil Bio | 50.29 Mn | 50.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 104.00 Mn |
| Dec 31, 2021 | 67.00 Mn |
| Sep 30, 2021 | 44.20 Mn |
| Jun 30, 2021 | 22.60 Mn |
| Dec 31, 2020 | 6.30 Mn |